• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠静脉注射和口服二氢麦角碱后的药代动力学

Pharmacokinetics of dihydroergosine in rats after intravenous and oral administration.

作者信息

Mrhar A, Kopitar Z, Kozjek F, Krusic L, Lenardic A

出版信息

Eur J Drug Metab Pharmacokinet. 1983;8(1):17-20. doi: 10.1007/BF03189576.

DOI:10.1007/BF03189576
PMID:6861791
Abstract

Wistar rats received an intravenous dose of 20 micrograms/kg and an oral does of 40 micrograms/kg 3H-Dihydroergosine. Concentrations of radioactivity were measured in plasma, bile, urine, and faeces, and pharmacokinetical parameters of an open two compartment model were calculated. After intravenous injection and oral administration 3H-Dihydroergosine is rapidly lost from the central compartment with distribution rate constants alpha = 0.889 h-1 and beta = 0.722 h-1, respectively. Biological half life in the elimination phase after both application is nearly the same t 1/2 = 13.6 h. The volume of central compartment is Vc = 3.075 l/kg and the volume of distribution Vd beta = 30.75 l/kg. The fraction of 3H-Dihydroergosine absorbed after oral administration, calculated from areas under the curves upon oral and intravenous administration, is 31%. The percentage of 3H-radioactivity eliminated with bile was 98.3% of the dose within 72 hours after intravenous and 29.3% after oral administration. The main portion of the administered 3H-radioactivity was recovered in faeces -66.1% after intravenous and 81.3% after oral administration, while only 17.4% and 4.9% of the administered dose was eliminated in the urine within 120 hours, respectively.

摘要

将20微克/千克的剂量静脉注射给Wistar大鼠,并口服40微克/千克的3H - 二氢麦角隐亭。测量血浆、胆汁、尿液和粪便中的放射性浓度,并计算开放二室模型的药代动力学参数。静脉注射和口服给药后,3H - 二氢麦角隐亭从中央室迅速消除,分布速率常数α分别为0.889小时-1和β为0.722小时-1。两种给药方式后消除相的生物半衰期几乎相同,t1/2 = 13.6小时。中央室的容积为Vc = 3.075升/千克,分布容积Vdβ = 30.75升/千克。根据口服和静脉给药后的曲线下面积计算,口服给药后3H - 二氢麦角隐亭的吸收分数为31%。静脉注射后72小时内,经胆汁消除的3H放射性占剂量的98.3%,口服给药后为29.3%。给药的3H放射性主要在粪便中回收——静脉注射后为66.1%,口服给药后为81.3%,而在120小时内,经尿液消除的给药剂量分别仅为17.4%和4.9%。

相似文献

1
Pharmacokinetics of dihydroergosine in rats after intravenous and oral administration.大鼠静脉注射和口服二氢麦角碱后的药代动力学
Eur J Drug Metab Pharmacokinet. 1983;8(1):17-20. doi: 10.1007/BF03189576.
2
Bioavailability of dihydroergosine in healthy volunteers.健康志愿者中二氢麦角碱的生物利用度。
Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):1-4. doi: 10.1007/BF03189854.
3
Dihydroergosine pharmacokinetic modelling and simulation.二氢麦角碱的药代动力学建模与模拟。
Eur J Drug Metab Pharmacokinet. 1983;8(1):21-3. doi: 10.1007/BF03189577.
4
Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.给斯普拉格-道利大鼠静脉注射、口服和气管内给予3H-醋酸艾洛米松后的药代动力学、蛋白结合及代谢情况
Arzneimittelforschung. 1998 Apr;48(4):371-8.
5
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
6
Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.抗心律失常药物[3H] - 双苯丙胺在大鼠体内的药代动力学和代谢
Arzneimittelforschung. 1989 Nov;39(11):1430-5.
7
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
8
Metabolism, kinetics and metabolic activity of the beta-cytotropic antidiabetic 4-(5-isobutylpyrimidinyl-2)-sulphamylphenylacetic acid-3-chloro-6-methoxyanilide sodium (glydanile sodium) in man after oral and intravenous administration.
Arzneimittelforschung. 1976 Feb;26(2):278-86.
9
The pharmacokinetics and tissue distribution of gomphoside in Wistar rats.贯众皂苷在Wistar大鼠体内的药代动力学及组织分布
Eur J Drug Metab Pharmacokinet. 1989 Apr-Jun;14(2):117-25. doi: 10.1007/BF03190851.
10
Pentachlorophenol toxicokinetics after intravenous and oral administration to rat.大鼠静脉注射和口服五氯苯酚后的毒代动力学
Xenobiotica. 1991 Dec;21(12):1547-58. doi: 10.3109/00498259109044404.

引用本文的文献

1
Dihydroergosine pharmacokinetic modelling and simulation.二氢麦角碱的药代动力学建模与模拟。
Eur J Drug Metab Pharmacokinet. 1983;8(1):21-3. doi: 10.1007/BF03189577.
2
Bioavailability of dihydroergosine in healthy volunteers.健康志愿者中二氢麦角碱的生物利用度。
Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):1-4. doi: 10.1007/BF03189854.